<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01838473</url>
  </required_header>
  <id_info>
    <org_study_id>SMWS03</org_study_id>
    <nct_id>NCT01838473</nct_id>
  </id_info>
  <brief_title>In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users</brief_title>
  <acronym>SMWS03</acronym>
  <official_title>In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Four Brands of Swedish 'Snus' in Regular Snus Users.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Contract Research Organization el AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swedish Match AB</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Contract Research Organization el AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In an open label, randomized, two-way cross-over study, 32 male healthy regular snus users
      will be given repeated doses of four different types of portion snus: &quot;General&quot;, &quot;Catch&quot;,
      &quot;Catch Mini&quot; and &quot;Catch Dry Mini&quot;. Each portion of used snus will be collected and frozen
      (-20 oC) pending analysis of lead (Pb), cadmium (Cd), nicotine and tobacco specific
      nitrosamines (TSNAs). Unused snus is collected and deep frozen for analysis and calculation
      of extracted dose. Calculations of extracted amount of lead, cadmium, nicotine and tobacco
      specific nitrosamines (TSNAs) respectively, will be done for each type of snus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparisons:

      A= &quot;General Portion&quot; 1 g portion snus containing approximately 8 mg nicotine per portion.

      B= &quot;Catch Licorice Portion&quot; 1 g portion snus containing approximately 8 mg nicotine per
      portion.

      C= &quot;Catch Licorice Portion Mini&quot; 0.5 g portion snus containing approximately 4 mg nicotine
      per portion.

      D= &quot;Catch Dry Licorice Portion Mini&quot; 0.3 g portion snus containing approximately 4 mg
      nicotine per portion.

      Swedish portion snus will be administered once every hour (4 administrations/brand) and will
      be kept between the upper lip and the gum for 30 minutes. Preload of own brand each morning.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Actual">April 2005</completion_date>
  <primary_completion_date type="Actual">August 2004</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In-vivo extraction of cadmium</measure>
    <time_frame>30 minutes' use</time_frame>
    <description>Extracted amount = mean of 10 unused sachets - residual amount</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>in-vivo extraction of tobacco specific nitrosamines (TSNAs)</measure>
    <time_frame>30 minutes' use</time_frame>
    <description>Extracted amount = mean of 10 unused sachets - residual amount in used sachet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-vivo extraction of lead</measure>
    <time_frame>30 minutes' use</time_frame>
    <description>Extracted amount = mean of 10 unused sachets - residual amount in one used sachet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-vivo extraction of nicotine</measure>
    <time_frame>30 minutes' use</time_frame>
    <description>Extracted amount = mean of 10 unused sachets - residual amount in one used sachet</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Smoking Cessation</condition>
  <condition>Harm Reduction</condition>
  <arm_group>
    <arm_group_label>General 1 g pouch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral pouch 0.3-1g, single dose. One pouch administered over 30 minutes. Buccal Administration of nicotine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Catch Licoice 1 g pouch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral pouch 1g, single dose. One pouch administered over 30 minutes. Buccal Administration of nicotine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Catch Licorice Mini 0.5 g pouch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral pouch 0.5g, single dose. One pouch administered over 30 minutes. Buccal Administration of nicotine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Catch Licorice dry mini 0.3 g pouch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral pouch 0.3 g, single dose. One pouch administered over 30 minutes. Buccal Administration of nicotine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Buccal Administration of nicotine</intervention_name>
    <description>Oral pouch 1g, single dose. One pouch administered over 30 minutes.</description>
    <arm_group_label>General 1 g pouch</arm_group_label>
    <other_name>Smokeless tobacco</other_name>
    <other_name>ST</other_name>
    <other_name>Potential Exposure Reduced Product</other_name>
    <other_name>PREP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Buccal Administration of nicotine</intervention_name>
    <description>Oral pouch 1g, single dose. One pouch administered over 30 minutes.</description>
    <arm_group_label>Catch Licoice 1 g pouch</arm_group_label>
    <other_name>Smokeless tobacco</other_name>
    <other_name>ST</other_name>
    <other_name>Potential Exposure Reduced Product</other_name>
    <other_name>PREP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Buccal Administration of nicotine</intervention_name>
    <description>Oral pouch 0.5 g, single dose. One pouch administered over 30 minutes.</description>
    <arm_group_label>Catch Licorice Mini 0.5 g pouch</arm_group_label>
    <other_name>Smokeless tobacco</other_name>
    <other_name>ST</other_name>
    <other_name>Potential Exposure Reduced Product</other_name>
    <other_name>PREP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Buccal Administration of nicotine</intervention_name>
    <description>Oral pouch 0.3 g, single dose. One pouch administered over 30 minutes.</description>
    <arm_group_label>Catch Licorice dry mini 0.3 g pouch</arm_group_label>
    <other_name>Smokeless tobacco</other_name>
    <other_name>ST</other_name>
    <other_name>Potential Exposure Reduced Product</other_name>
    <other_name>PREP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non-smokers, 18 to 50 years of age.

          -  Habitual use of &gt; 7 portions snus daily since minimum 1 year.

          -  Healthy according to the health declaration and interview.

          -  Written informed consent given.

        Exclusion Criteria:

          -  Concurrent participation in another clinical trial.

          -  History of allergy.

          -  History of allergy.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik Lunell, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Croel AB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CROel AB</name>
      <address>
        <city>Helsingborg</city>
        <zip>SE25284</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2012</study_first_submitted>
  <study_first_submitted_qc>April 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2013</study_first_posted>
  <last_update_submitted>April 19, 2013</last_update_submitted>
  <last_update_submitted_qc>April 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Contract Research Organization el AB</investigator_affiliation>
    <investigator_full_name>Erik Lunell, MD, PhD</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>smokeless tobacco</keyword>
  <keyword>Nicotine</keyword>
  <keyword>Cadmium</keyword>
  <keyword>lead</keyword>
  <keyword>Tobacco Specific Nitrosamines</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Lobeline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

